ICPT Annual CFI
$261.85 M
+$191.12 M+270.23%
31 December 2022
Summary:
As of February 5, 2025, ICPT annual cash flow from investing activities is $261.85 million, with the most recent change of +$191.12 million (+270.23%) on December 31, 2022. During the last 3 years, it has risen by +$450.84 million (+238.55%).ICPT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Quarterly CFI
$59.77 M
-$37.17 M-38.34%
30 September 2023
Summary:
As of February 5, 2025, ICPT quarterly cash flow from investing activities is $59.77 million, with the most recent change of -$37.17 million (-38.34%) on September 30, 2023. Over the past year, it has dropped by -$271.81 million (-81.97%).ICPT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT TTM CFI
$161.11 M
-$271.81 M-62.79%
30 September 2023
Summary:
As of February 5, 2025, ICPT TTM cash flow from investing activities is $161.11 million, with the most recent change of -$271.81 million (-62.79%) on September 30, 2023. Over the past year, it has dropped by -$171.00 million (-51.49%).ICPT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +270.2% | -82.0% | -51.5% |
| 3 y3 years | +238.6% | +70.3% | -19.0% |
| 5 y5 years | -9.0% | +89.5% | +185.3% |
ICPT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -9.0% | -82.0% | -62.8% |
Intercept Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $59.77 M(-38.3%) | $161.11 M(-62.8%) |
| June 2023 | - | $96.95 M(+63.4%) | $432.92 M(+29.1%) |
| Mar 2023 | - | $59.32 M(-208.0%) | $335.39 M(+28.1%) |
| Dec 2022 | $261.85 M(+270.2%) | -$54.94 M(-116.6%) | $261.85 M(-21.2%) |
| Sept 2022 | - | $331.58 M(<-9900.0%) | $332.11 M(-496.7%) |
| June 2022 | - | -$578.00 K(-95.9%) | -$83.73 M(+140.4%) |
| Mar 2022 | - | -$14.22 M(-192.8%) | -$34.83 M(-149.3%) |
| Dec 2021 | $70.73 M(-56.6%) | $15.33 M(-118.2%) | $70.73 M(-17.0%) |
| Sept 2021 | - | -$84.26 M(-274.4%) | $85.24 M(-58.3%) |
| June 2021 | - | $48.31 M(-47.1%) | $204.59 M(+12.2%) |
| Mar 2021 | - | $91.34 M(+206.1%) | $182.34 M(+12.0%) |
| Dec 2020 | $162.82 M(-186.2%) | $29.84 M(-15.0%) | $162.82 M(-18.1%) |
| Sept 2020 | - | $35.09 M(+34.6%) | $198.86 M(+10.3%) |
| June 2020 | - | $26.06 M(-63.7%) | $180.24 M(-185.2%) |
| Mar 2020 | - | $71.82 M(+9.0%) | -$211.64 M(+12.0%) |
| Dec 2019 | -$188.99 M(+293.2%) | $65.89 M(+299.9%) | -$188.99 M(-13.3%) |
| Sept 2019 | - | $16.48 M(-104.5%) | -$217.95 M(+7.4%) |
| June 2019 | - | -$365.82 M(-487.2%) | -$202.88 M(+898.4%) |
| Mar 2019 | - | $94.47 M(+155.8%) | -$20.32 M(-57.7%) |
| Dec 2018 | -$48.07 M(-116.7%) | $36.93 M(+17.1%) | -$48.07 M(-19.4%) |
| Sept 2018 | - | $31.54 M(-117.2%) | -$59.60 M(-367.4%) |
| June 2018 | - | -$183.26 M(-374.7%) | $22.29 M(-91.2%) |
| Mar 2018 | - | $66.72 M(+162.7%) | $254.48 M(-11.6%) |
| Dec 2017 | $287.77 M | $25.39 M(-77.6%) | $287.77 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $113.43 M(+131.8%) | $288.55 M(-519.4%) |
| June 2017 | - | $48.93 M(-51.1%) | -$68.80 M(+51.5%) |
| Mar 2017 | - | $100.01 M(+282.1%) | -$45.40 M(-24.5%) |
| Dec 2016 | -$60.13 M(-84.6%) | $26.17 M(-110.7%) | -$60.13 M(-2.2%) |
| Sept 2016 | - | -$243.92 M(-437.2%) | -$61.49 M(-130.8%) |
| June 2016 | - | $72.33 M(-15.2%) | $199.95 M(-189.4%) |
| Mar 2016 | - | $85.28 M(+243.6%) | -$223.67 M(-42.6%) |
| Dec 2015 | -$389.47 M(+303.2%) | $24.82 M(+41.6%) | -$389.47 M(+2.2%) |
| Sept 2015 | - | $17.52 M(-105.0%) | -$381.25 M(-5.6%) |
| June 2015 | - | -$351.29 M(+336.3%) | -$403.71 M(+118.4%) |
| Mar 2015 | - | -$80.52 M(-343.7%) | -$184.82 M(+91.4%) |
| Dec 2014 | -$96.58 M(+37.6%) | $33.04 M(-769.3%) | -$96.58 M(-31.0%) |
| Sept 2014 | - | -$4.94 M(-96.3%) | -$139.92 M(-6.1%) |
| June 2014 | - | -$132.39 M(-1818.0%) | -$149.08 M(+174.8%) |
| Mar 2014 | - | $7.71 M(-174.8%) | -$54.26 M(-22.7%) |
| Dec 2013 | -$70.21 M(+8.3%) | -$10.30 M(-26.9%) | -$70.21 M(-43.8%) |
| Sept 2013 | - | -$14.09 M(-62.5%) | -$124.87 M(+12.7%) |
| June 2013 | - | -$37.57 M(+355.3%) | -$110.78 M(+51.6%) |
| Mar 2013 | - | -$8.25 M(-87.3%) | -$73.09 M(+12.7%) |
| Dec 2012 | -$64.86 M(>+9900.0%) | -$64.95 M(>+9900.0%) | -$64.86 M(<-9900.0%) |
| Sept 2012 | - | -$700.00(-100.6%) | $96.30 K(-0.7%) |
| June 2012 | - | $120.80 K(-607.6%) | $97.00 K(-507.6%) |
| Mar 2012 | - | -$23.80 K | -$23.80 K |
| Dec 2011 | -$66.00 K(-214.0%) | - | - |
| Dec 2010 | $57.90 K | - | - |
FAQ
- What is Intercept Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual CFI year-on-year change?
- What is Intercept Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly CFI year-on-year change?
- What is Intercept Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals TTM CFI year-on-year change?
What is Intercept Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ICPT is $261.85 M
What is the all time high annual CFI for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual cash flow from investing activities is $287.77 M
What is Intercept Pharmaceuticals annual CFI year-on-year change?
Over the past year, ICPT annual cash flow from investing activities has changed by +$191.12 M (+270.23%)
What is Intercept Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ICPT is $59.77 M
What is the all time high quarterly CFI for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly cash flow from investing activities is $331.58 M
What is Intercept Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ICPT quarterly cash flow from investing activities has changed by -$271.81 M (-81.97%)
What is Intercept Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ICPT is $161.11 M
What is the all time high TTM CFI for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high TTM cash flow from investing activities is $432.92 M
What is Intercept Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ICPT TTM cash flow from investing activities has changed by -$171.00 M (-51.49%)